• Home
  • Pharmaceuticals and Healthcare
Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market - Global Outlook and Forecast 2021-2027

Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ687547 | No. of Pages: 109 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2021 
This report contains market size and forecasts of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing in Global, including the following market information:
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Segment Percentages, By Type, 2020 (%)
AAV
Adenoviral
Lentiviral
Retroviral
Plasmid DNA
Other Vectors

China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Segment Percentages, By Application, 2020 (%)
Cancers
Inherited Disorders
Viral Infections
Others

Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
bluebird bio
Novasep
Spark Therapeutics
Vigene Biosciences
1 Introduction to Research & Analysis Reports
    1.1 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Overall Market Size
    2.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size: 2021 VS 2027
    2.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players in Global Market
    3.2 Top Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Companies Ranked by Revenue
    3.3 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Companies
    3.4 Top 3 and Top 5 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players in Global Market
        3.6.1 List of Global Tier 1 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Companies
        3.6.2 List of Global Tier 2 and Tier 3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Markets, 2021 & 2027
        4.1.2 AAV
        4.1.3 Adenoviral
        4.1.4 Lentiviral
        4.1.5 Retroviral
        4.1.6 Plasmid DNA
        4.1.7 Other Vectors
    4.2 By Type - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue & Forecasts
        4.2.1 By Type - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2016-2021
        4.2.2 By Type - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2022-2027
        4.2.3 By Type - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2021 & 2027
        5.1.2 Cancers
        5.1.3 Inherited Disorders
        5.1.4 Viral Infections
        5.1.5 Others
    5.2 By Application - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue & Forecasts
        5.2.1 By Application - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2016-2021
        5.2.2 By Application - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2022-2027
        5.2.3 By Application - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2021 & 2027
    6.2 By Region - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue & Forecasts
        6.2.1 By Region - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2016-2021
        6.2.2 By Region - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2022-2027
        6.2.3 By Region - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2016-2027
        6.3.2 US Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
        6.3.3 Canada Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
        6.3.4 Mexico Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2016-2027
        6.4.2 Germany Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
        6.4.3 France Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
        6.4.4 U.K. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
        6.4.5 Italy Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
        6.4.6 Russia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
        6.4.7 Nordic Countries Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
        6.4.8 Benelux Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2016-2027
        6.5.2 China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
        6.5.3 Japan Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
        6.5.4 South Korea Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
        6.5.5 Southeast Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
        6.5.6 India Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2016-2027
        6.6.2 Brazil Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
        6.6.3 Argentina Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2016-2027
        6.7.2 Turkey Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
        6.7.3 Israel Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
        6.7.4 Saudi Arabia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
        6.7.5 UAE Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2016-2027
7 Players Profiles
    7.1 BioReliance
        7.1.1 BioReliance Corporate Summary
        7.1.2 BioReliance Business Overview
        7.1.3 BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.1.4 BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.1.5 BioReliance Key News
    7.2 Cobra Biologics
        7.2.1 Cobra Biologics Corporate Summary
        7.2.2 Cobra Biologics Business Overview
        7.2.3 Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.2.4 Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.2.5 Cobra Biologics Key News
    7.3 Oxford BioMedica
        7.3.1 Oxford BioMedica Corporate Summary
        7.3.2 Oxford BioMedica Business Overview
        7.3.3 Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.3.4 Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.3.5 Oxford BioMedica Key News
    7.4 UniQure
        7.4.1 UniQure Corporate Summary
        7.4.2 UniQure Business Overview
        7.4.3 UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.4.4 UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.4.5 UniQure Key News
    7.5 FinVector
        7.5.1 FinVector Corporate Summary
        7.5.2 FinVector Business Overview
        7.5.3 FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.5.4 FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.5.5 FinVector Key News
    7.6 MolMed
        7.6.1 MolMed Corporate Summary
        7.6.2 MolMed Business Overview
        7.6.3 MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.6.4 MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.6.5 MolMed Key News
    7.7 MassBiologics
        7.7.1 MassBiologics Corporate Summary
        7.7.2 MassBiologics Business Overview
        7.7.3 MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.4.4 MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.7.5 MassBiologics Key News
    7.8 Richter-Helm
        7.8.1 Richter-Helm Corporate Summary
        7.8.2 Richter-Helm Business Overview
        7.8.3 Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.8.4 Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.8.5 Richter-Helm Key News
    7.9 FUJIFILM Diosynth Biotechnologies
        7.9.1 FUJIFILM Diosynth Biotechnologies Corporate Summary
        7.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
        7.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.9.4 FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.9.5 FUJIFILM Diosynth Biotechnologies Key News
    7.10 Lonza
        7.10.1 Lonza Corporate Summary
        7.10.2 Lonza Business Overview
        7.10.3 Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.10.4 Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.10.5 Lonza Key News
    7.11 Aldevron
        7.11.1 Aldevron Corporate Summary
        7.11.2 Aldevron Business Overview
        7.11.3 Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.11.4 Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.11.5 Aldevron Key News
    7.12 Eurogentec
        7.12.1 Eurogentec Corporate Summary
        7.12.2 Eurogentec Business Overview
        7.12.3 Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.12.4 Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.12.5 Eurogentec Key News
    7.13 Cell and Gene Therapy Catapult
        7.13.1 Cell and Gene Therapy Catapult Corporate Summary
        7.13.2 Cell and Gene Therapy Catapult Business Overview
        7.13.3 Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.13.4 Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.13.5 Cell and Gene Therapy Catapult Key News
    7.14 Biovian
        7.14.1 Biovian Corporate Summary
        7.14.2 Biovian Business Overview
        7.14.3 Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.14.4 Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.14.5 Biovian Key News
    7.15 Thermo Fisher Scientific (Brammer Bio)
        7.15.1 Thermo Fisher Scientific (Brammer Bio) Corporate Summary
        7.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
        7.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.15.4 Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.15.5 Thermo Fisher Scientific (Brammer Bio) Key News
    7.16 VGXI
        7.16.1 VGXI Corporate Summary
        7.16.2 VGXI Business Overview
        7.16.3 VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.16.4 VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.16.5 VGXI Key News
    7.17 PlasmidFactory
        7.17.1 PlasmidFactory Corporate Summary
        7.17.2 PlasmidFactory Business Overview
        7.17.3 PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.17.4 PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.17.5 PlasmidFactory Key News
    7.18 bluebird bio
        7.18.1 bluebird bio Corporate Summary
        7.18.2 bluebird bio Business Overview
        7.18.3 bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.18.4 bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.18.5 bluebird bio Key News
    7.19 Novasep
        7.19.1 Novasep Corporate Summary
        7.19.2 Novasep Business Overview
        7.19.3 Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.19.4 Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.19.5 Novasep Key News
    7.20 Spark Therapeutics
        7.20.1 Spark Therapeutics Corporate Summary
        7.20.2 Spark Therapeutics Business Overview
        7.20.3 Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.20.4 Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.20.5 Spark Therapeutics Key News
    7.21 Vigene Biosciences
        7.21.1 Vigene Biosciences Corporate Summary
        7.21.2 Vigene Biosciences Business Overview
        7.21.3 Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
        7.21.4 Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (2016-2021)
        7.21.5 Vigene Biosciences Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com